The winner will be announced on 27 November 2025, during our 10th anniversary celebration of Oslo Cancer Cluster Innovation Park and the official opening of John Ugelstad’s House.

Please visit the event page

Application deadline: 19 September 2025, 13:00
Decision announcement: 27 November 2025

Submit your nomination here

This prestigious award recognizes individuals, companies, or public institutions in Norway that have brought meaningful improvements for cancer patients, showcasing originality, quality, and measurable impact. Nominations should be submitted by September 19th.

The award includes a grant of NOK 300 000.

Who can nominate?

Any individual or group may submit a nomination. You are encouraged to nominate more than one candidate if relevant; however, each nomination must be submitted through a separate form. Please note that the same person or entity may only receive the prize once.

Nomination requirements

Each nomination must include a letter of motivation that describes the following:

• The candidate’s background
• A clear explanation of their innovative efforts
• The impact of these efforts on cancer treatment in Norway

Evaluation criteria

All nominations will be reviewed by a committee appointed by the Norwegian Cancer Society. The committee will shortlist three candidates, providing justifications for their selections to support the final decisions of the Society’s Board.

The prize will be awarded to a candidate who has demonstrated the following:

• Innovative capacity and ability to successfully deliver a product or service of benefit to cancer patients
• Documented positive impact for cancer patients
• National and/or international recognition of their work

For full details, please see: Guidelines-The-Norwegian-Cancer-Societys-Prize-for-Innovation-2025.pdf

Contact information

For questions about the call:

• Simen Enger, mobile: 476 41 808

For technical support:

• Maj Angell, mobile: 913 38 088

Or email: forskningsadministrasjon@kreftforeningen.no